These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1136 related articles for article (PubMed ID: 10597778)

  • 61. Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection.
    Giorgi JV; Lyles RH; Matud JL; Yamashita TE; Mellors JW; Hultin LE; Jamieson BD; Margolick JB; Rinaldo CR; Phair JP; Detels R;
    J Acquir Immune Defic Syndr; 2002 Apr; 29(4):346-55. PubMed ID: 11917238
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [The correlation between HLA-DR or CD38 expression in CD8(+)T cells and CD4(+)T cells count in treatment-naive HIV/AIDS patients].
    Xie J; Qiu Z; Han Y; Li Y; Song X; Li T
    Zhonghua Nei Ke Za Zhi; 2016 Jan; 55(1):36-9. PubMed ID: 26796651
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Limited long-term naive CD4+ T cell reconstitution in patients experiencing viral load rebounds during HAART.
    Choremi-Papadopoulou H; Tsalimalma K; Dafni U; Dimitracopoulou A; Kordossis T
    J Med Virol; 2004 Jun; 73(2):235-43. PubMed ID: 15122798
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Subcutaneous interleukin-2 in combination with anti-retroviral therapy for treatment of HIV-1-infected subjects.
    Larsen CS; Ostergård L; Møller BK; Buhl MR
    Scand J Infect Dis; 2000; 32(2):153-60. PubMed ID: 10826900
    [TBL] [Abstract][Full Text] [Related]  

  • 65. T cell changes after combined nucleoside analogue therapy in HIV primary infection.
    Carcelain G; Blanc C; Leibowitch J; Mariot P; Mathez D; Schneider V; Saimot AG; Damond F; Simon F; Debré P; Autran B; Girard PM
    AIDS; 1999 Jun; 13(9):1077-81. PubMed ID: 10397538
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lymphocyte subsets in human tonsils: the effect of age and infection.
    Rosenmann E; Rabinowitz R; Schlesinger M
    Pediatr Allergy Immunol; 1998 Aug; 9(3):161-7. PubMed ID: 9814732
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Changes of lymphocyte apoptosis associated with sequential introduction of highly active antiretroviral therapy.
    Wasmuth JC; Hackbarth F; Rockstroh JK; Sauerbruch T; Spengler U
    HIV Med; 2003 Apr; 4(2):111-9. PubMed ID: 12702131
    [TBL] [Abstract][Full Text] [Related]  

  • 68. HIV-1 low-level viremia affects T cell activation rather than T cell development in school-age children, adolescents, and young adults during antiretroviral therapy.
    Han J; Mu W; Zhao H; Hao Y; Song C; Zhou H; Sun X; Li G; Dai G; Zhang Y; Zhang F; Zeng H
    Int J Infect Dis; 2020 Feb; 91():210-217. PubMed ID: 31821891
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The role of extended-release niacin on immune activation and neurocognition in HIV-infected patients treated with antiretroviral therapy - CTN PT006: study protocol for a randomized controlled trial.
    Lebouché B; Jenabian MA; Singer J; Graziani GM; Engler K; Trottier B; Thomas R; Brouillette MJ; Routy JP
    Trials; 2014 Oct; 15():390. PubMed ID: 25293882
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Nucleoside-free boosted double PI regimen: significant CD4+ T-cell recovery in patients with poor immunologic response despite virologic suppression.
    Lehmann C; Jung N; Hofmann A; Cornely OA; Wyen C; Fätkenheuer G; Hartmann P
    Curr HIV Res; 2008 Nov; 6(6):555-9. PubMed ID: 18991621
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pilot study of a combination of highly active antiretroviral therapy and cytokines to induce HIV-1 remission.
    Lafeuillade A; Poggi C; Chadapaud S; Hittinger G; Chouraqui M; Pisapia M; Delbeke E
    J Acquir Immune Defic Syndr; 2001 Jan; 26(1):44-55. PubMed ID: 11176268
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Assessment of CD8 T cell immune activation markers to monitor response to antiretroviral therapy among HIV-1 infected patients in Côte d'Ivoire.
    Ondoa P; Koblavi-Dème S; Borget MY; Nolan ML; Nkengasong JN; Kestens L
    Clin Exp Immunol; 2005 Apr; 140(1):138-48. PubMed ID: 15762885
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Expression of regeneration and tolerance factor correlates directly with human immunodeficiency virus infection and inversely with hepatitis C virus infection.
    Sung CC; Boomer JS; Givens TS; DuChateau BK; Lepe MR; Feller A; Westerman MP; Gilman-Sachs A; Chedid A; Beaman KD
    Clin Diagn Lab Immunol; 2000 Mar; 7(2):200-5. PubMed ID: 10702493
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Activation and proliferation of CD8+ T cells in lymphoid tissues of HIV-1-infected individuals in the absence of the high-affinity IL-2 receptor.
    Brinchmann JE; Røsok BI; Spurkland A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):332-8. PubMed ID: 9833741
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study.
    Giorgi JV; Liu Z; Hultin LE; Cumberland WG; Hennessey K; Detels R
    J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):904-12. PubMed ID: 7686224
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.
    Autran B; Carcelain G; Li TS; Blanc C; Mathez D; Tubiana R; Katlama C; Debré P; Leibowitch J
    Science; 1997 Jul; 277(5322):112-6. PubMed ID: 9204894
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Factors associated with CD8+ T-cell activation in HIV-1-infected patients on long-term antiretroviral therapy.
    Zheng L; Taiwo B; Gandhi RT; Hunt PW; Collier AC; Flexner C; Bosch RJ
    J Acquir Immune Defic Syndr; 2014 Oct; 67(2):153-60. PubMed ID: 25072610
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunologic reconstitution after 1 year of highly active antiretroviral therapy, with or without protease inhibitors.
    Plana M; Martínez C; García F; Maleno MJ; Barceló JJ; García A; Lejeune M; Vidal C; Cruceta A; Miró JM; Pumarola T; Gallart T; Gatell JM
    J Acquir Immune Defic Syndr; 2002 Apr; 29(5):429-34. PubMed ID: 11981357
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Immunophenotypic characterization of peripheral T lymphocytes in Mycobacterium tuberculosis infection and disease.
    Rodrigues DS; Medeiros EA; Weckx LY; Bonnez W; Salomão R; Kallas EG
    Clin Exp Immunol; 2002 Apr; 128(1):149-54. PubMed ID: 11982602
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection.
    Oxenius A; Price DA; Günthard HF; Dawson SJ; Fagard C; Perrin L; Fischer M; Weber R; Plana M; García F; Hirschel B; McLean A; Phillips RE
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13747-52. PubMed ID: 12370434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.